Y Wang

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.

Y Wang, Riccardo Perfetti, Nigel H. Greig et al. · Journal of Clinical Investigation · 1997 · 173 citations · Full text

Aging, Biogerontology, Glucose Tolerance +21

Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action.

Josephine M. Egan, Chahrzad Montrose‐Rafizadeh, Y Wang et al. · Endocrinology · 1994 · 115 citations

Basal Uptake, Insulin Signaling, Gastrointestinal Peptide Hormone +21

Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.

Y Wang, JM Egan, Margarita Raygada et al. · Endocrinology · 1995 · 85 citations

Immunology, Acid Stability, Insulin Signaling +23

Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions

Y Wang, HK Kole, Chahrzad Montrose‐Rafizadeh et al. · Journal of Molecular Endocrinology · 1997 · 55 citations

Glucose Uptake, Insulin Signaling, Metabolic Syndrome +20

Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness

Chahrzad Montrose‐Rafizadeh, Y Wang, Andrzej M. Janczewski et al. · Molecular and Cellular Endocrinology · 1997 · 34 citations

Glucagon-like Peptide-1 Receptor, Signal Transduction, Molecular Physiology +11